Leap Therapeutics Aktie
WKN DE: A2DK5X / ISIN: US52187K1016
13.05.2025 13:02:52
|
Leap Therapeutics, Inc. (LPTX) Q1 Loss Beats Estimates
(RTTNews) - Leap Therapeutics, Inc. (LPTX) (LPTX) reported Loss for first quarter that beat the Street estimates.
The company's bottom line totaled -$15.44 million, or -$0.37 per share. This compares with -$13.82 million, or -$0.51 per share, last year.
Analysts on average had expected the company to earn -$0.38 per share. Analysts' estimates typically exclude special items.
Leap Therapeutics, Inc. (LPTX) earnings at a glance (GAAP) :
-Earnings: -$15.44 Mln. vs. -$13.82 Mln. last year. -EPS: -$0.37 vs. -$0.51 last year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Leap Therapeutics Inc Registered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |